Increased p53 protein expression in malignant mammary phyllodes tumors

Modern Pathology

Volumn 15, Issue 7, 2002, Pages 734-740

  Tse, Gary M K ^a   Putti, Thomas C ^c   Kung, Fred Y L ^a   Scolyer, Richard A ^d   Law, Bonita K B ^a   Lau, Tai Shing ^b   Lee, C Soon ^d  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^d ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Breast; Immunohistochemistry; Malignant; p53; Pathology; Phyllodes tumor

Indexed keywords

PROTEIN P53;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; CYSTOSARCOMA PHYLLOIDES; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; STAINING; STATISTICAL ANALYSIS; TUMOR VOLUME;

ADOLESCENT; ADULT; AGE FACTORS; BREAST NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PHYLLODES TUMOR; PROGNOSIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0036076726     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MP.0000018978.75312.5C     Document Type: Article

References (26)

1. Ultrasound, x-ray mammography, and histopathology of cystosarcoma phyllodes
2. Sarcoma of the breast
3. Treatment options and recurrence potential for cystosarcoma phyllodes
4. Phyllodes tumor of the breast: A clinicopathologic study of 34 cases
5. Phyllodes tumors
6. p53 and human cancers
7. Stabilised p53 facilitates aneuploid clonal divergence in colorectal cancer
8. p53 mutations in Barrett's adenocarcinoma and high-grade dysplasia
9. Malignant phyllodes tumours of the breast display increased stromal p53 protein expression
10. p53 expression in phyllodes tumours is associated with histological features of malignancy but does not predict outcome
11. Patterns of p53 expression in phyllodes tumors of the breast - An immunohistochemical study
12. Prognostic evaluation of proliferative activity and DNA content in the phyllodes tumor of the breast: Immunohistochemical and flow cytometric study of 118 cases
13. Altered expressiopn of p53 and its regulated proteins in phyllodes tumours of the breast
14. Phyllodes tumour: Cytologic and histologic presentation of 22 cases, and immunohistochemical demonstration of p53
15. Phyllodes tumor of the breast: EGFR family expression and relation to clinicopathological features
16. The treatment and prognosis of patients with phyllodes tumor of the breast: An analysis of 179 cases
17. Prognostic factors in cystosarcoma phyllodes. A clinicopathologic study of 77 patients
18. Expression of CD34 and bcl-2 in phyllodes tumours, fibroadenomas and spindle cell lesions of the breast
19. Mammary fibroadenoma and some phyllodes tumour stroma are composed of CD34+ fibroblasts and factor XIIIa dendrophages
20. Abundant expression of immunoreactive endothelin 1 in mammary phyllodes tumor: Possible paracrine role of endothelin 1 in the growth of stromal cells in phyllodes tumor
21. The role of p53 mutation and Ki-67 proliferation index in the diagnosis and progression of phyllodes tumor of the breast
22. Increased microvessel density in malignant and borderline mammary phyllodes tumours
23. Molecular analysis of phyllodes tumors reveals distinct changes in the epithelial and stromal components
24. Cytogenetics, immunostaining for fibroblastic growth factors, p53 sequencing and clinical features of two cases of cystosarcoma phyllodes
25. p53 protein expression and gene mutation in phyllodes tumors of the breast